Skip to site content
U.S. Department of Health and Human Services
Division of Diabetes Treatment and Prevention (DDTP)

Overview of Cancer and Cancer Screening in AI/AN People with Diabetes

Quiz for CE Credit

This quiz consists of multiple choice questions with one correct answer.
Please select one answer for each question, then click the Submit Answers button at the end of the quiz.

 
1. Improving health trends in AI/AN people include a decrease in diabetes prevalence, and an overall decline in cancer incidence and mortality.


 
2. Common chronic diseases have a significant impact on individual health. Their development and outcomes are influenced by the environment and lifestyle choices, as well as, screening and early detection.


 
3. Although there is significant regional variation in incidence, mortality and patterns of cancer in AI/AN people. In general, when compared to the white US population there is a higher incidence of liver and bile duct, gallbladder, esophagus, stomach, colorectal, kidney, larynx, lung, uterine, cervix, and prostate cancers and myeloma in the AI/AN population.


 
4. According to a UK Clinical Practice Research Databank Study published in the Lancet Diabetes Endocrinology 2021, cancer surpassed vascular diseases as leading cause of death for people with diabetes in 2018.


 
5. Cancers more commonly associated with diabetes include: breast, colorectal, liver, pancreas, endometrium, esophagus, kidney, and bladder.


 
6. Obesity associated cancers include adenocarcinoma of the esophagus, breast cancer (in postmenopausal women), multiple myeloma, meningioma, colorectal cancer, and cancers of the endometrium, gallbladder, gastric cardia, kidney, liver, ovaries, pancreas, and thyroid.


 
7. People with diabetes may experience more complications and worse outcomes when they have cancer.


 
8. Metformin is known to lower incidence of gastric, colorectal, liver, breast and endometrial cancer.


 
9. Strategies for Cancer Risk Reduction include which of the following:








 
10. Guidelines for cancer screening continue to evolve.